SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. More Details
Flawless balance sheet and overvalued.
Share Price & News
How has SeaSpine Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SPNE is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: SPNE's weekly volatility (8%) has been stable over the past year.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: SPNE underperformed the US Medical Equipment industry which returned 34.6% over the past year.
Return vs Market: SPNE underperformed the US Market which returned 33% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is SeaSpine Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StSeaSpine Holdings (NASDAQ:SPNE) Shareholders Booked A 62% Gain In The Last Five Years
3 months ago | Simply Wall StIt Looks Like The CEO Of SeaSpine Holdings Corporation (NASDAQ:SPNE) May Be Underpaid Compared To Peers
10 months ago | Simply Wall StUS$19.66 - That's What Analysts Think SeaSpine Holdings Corporation (NASDAQ:SPNE) Is Worth After These Results
Is SeaSpine Holdings undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate SPNE's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate SPNE's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: SPNE is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: SPNE is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SPNE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SPNE is good value based on its PB Ratio (1.6x) compared to the US Medical Equipment industry average (4.6x).
How is SeaSpine Holdings forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SPNE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SPNE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SPNE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SPNE's revenue (14.7% per year) is forecast to grow faster than the US market (9.8% per year).
High Growth Revenue: SPNE's revenue (14.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SPNE's Return on Equity is forecast to be high in 3 years time
How has SeaSpine Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SPNE is currently unprofitable.
Growing Profit Margin: SPNE is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SPNE is unprofitable, but has reduced losses over the past 5 years at a rate of 0.3% per year.
Accelerating Growth: Unable to compare SPNE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SPNE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (40.5%).
Return on Equity
High ROE: SPNE has a negative Return on Equity (-10.31%), as it is currently unprofitable.
How is SeaSpine Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: SPNE's short term assets ($220.2M) exceed its short term liabilities ($43.6M).
Long Term Liabilities: SPNE's short term assets ($220.2M) exceed its long term liabilities ($15.5M).
Debt to Equity History and Analysis
Debt Level: SPNE is debt free.
Reducing Debt: SPNE has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SPNE has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SPNE has sufficient cash runway for 2.7 years if free cash flow continues to reduce at historical rates of 2.9% each year.
What is SeaSpine Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SPNE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SPNE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SPNE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SPNE's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SPNE's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Keith Valentine (53 yo)
Mr. Keith C. Valentine serves as Non-Executive Chair of the Board at Locate Bio Limited since January 5, 2021. He has been the Chief Executive Officer of SeaSpine Holdings Corporation since May 2015 and ha...
CEO Compensation Analysis
Compensation vs Market: Keith's total compensation ($USD2.09M) is about average for companies of similar size in the US market ($USD1.68M).
Compensation vs Earnings: Keith's compensation has increased whilst the company is unprofitable.
Experienced Management: SPNE's management team is seasoned and experienced (6 years average tenure).
Experienced Board: SPNE's board of directors are considered experienced (6.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SPNE insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.9%.
SeaSpine Holdings Corporation's company bio, employee growth, exchange listings and data sources
- Name: SeaSpine Holdings Corporation
- Ticker: SPNE
- Exchange: NasdaqGS
- Founded: 2015
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$579.098m
- Shares outstanding: 36.40m
- Website: https://www.seaspine.com
Number of Employees
- SeaSpine Holdings Corporation
- 5770 Armada Drive
- United States
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and i...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/20 22:39|
|End of Day Share Price||2021/09/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.